Biotech bullish Stocks: ImmunoGen (NASDAQ:IMGN), OXiGENE Inc (NASDAQ:OXGN), BioMarin Pharmaceutical Inc. (NASDAQ:BMRN), Celldex Therapeutics (NASDAQ:CLDX)

Shares of ImmunoGen Inc. (NASDAQ:IMGN), a biopharmaceutical company focused on developing therapies to fight cancer, advanced as much as 15% after research firm Canaccord Genuity initiated coverage on the company. ImmunoGen, Inc. (NASDAQ:IMGN) stock performance was 11.02% in last session and finished the day at $14.21. Traded volume was 2.85million shares in the last session and the average volume of the stock remained 858.46K shares. … Continue reading Biotech bullish Stocks: ImmunoGen (NASDAQ:IMGN), OXiGENE Inc (NASDAQ:OXGN), BioMarin Pharmaceutical Inc. (NASDAQ:BMRN), Celldex Therapeutics (NASDAQ:CLDX)

Healthcare bearish Stocks: Corcept Therapeutics Incorporated (NASDAQ:CORT), ImmunoCellular Therapeutics Ltd (NYSEMKT:IMUC), OXiGENE Inc (NASDAQ:OXGN), Depomed Inc (NASDAQ:DEPO)

Corcept Therapeutics, Inc. (NASDAQ:CORT) entered into a manufacturing agreement (the “Agreement”) with AAIPharma Services Corp. (“AAI”), pursuant to which AAI will manufacture and package Korlym® tablets (the “product”). AAI will manufacture the product in accordance with FDA and other regulatory requirements. Corcept Therapeutics Incorporated (NASDAQ:CORT) stock performance was -6.85% in last session and finished the day at $3.40. Traded volume was million shares in the … Continue reading Healthcare bearish Stocks: Corcept Therapeutics Incorporated (NASDAQ:CORT), ImmunoCellular Therapeutics Ltd (NYSEMKT:IMUC), OXiGENE Inc (NASDAQ:OXGN), Depomed Inc (NASDAQ:DEPO)

Novavax (NASDAQ:NVAX) Director Richard Douglas acquired 50,000 shares of Novavax stock in a transaction that occurred on Tuesday, March 25th. Novavax, Inc. (NASDAQ:NVAX) stock performance was 8.47% in last session and finished the day at $4.48. Traded volume was 7,425,052 million shares in the last session and the average volume of the stock remained 5.05 million shares. The beta of the stock remained 2.15. Novavax, … Continue reading Biotech Gainers: Novavax (NASDAQ:NVAX), OXiGENE Inc (NASDAQ:OXGN), Imprimis Pharmaceuticals (NASDAQ:IMMY), Oramed Pharmaceuticals (NASDAQ:ORMP)

Idenix Pharmaceuticals (NASDAQ:IDIX) , which had its hepatitis C drugs put on clinical hold because it had a similar structure to Bristol-Myers Squibb’s BMS-986094, which had serious cardiac side effects. Idenix Pharmaceuticals Inc (NASDAQ:IDIX) stock performance was -6.45% in last session and finished the day at $7.11. Traded volume was 3,306,727 million shares in the last session and the average volume of the stock remained … Continue reading Healthcare Most Volatile: Idenix Pharmaceuticals Inc (NASDAQ:IDIX), OXiGENE Inc (NASDAQ:OXGN), Intrexon (NYSE:XON), Enzon Pharmaceuticals (NASDAQ:ENZN)

Brower Piven, A Professional Corporation on Mar. 18 announced that a class action lawsuit has been commenced in the United States District Court for the Northern District of California on behalf of purchasers of Geron Corporation (NASDAQ:GERN) securities during the period between June 16, 2013 and March 11, 2014, inclusive (the “Class Period”). Geron Corporation (NASDAQ:GERN) stock performance was -8.06% in last session and finished … Continue reading Biotech Losers: Geron Corporation (NASDAQ:GERN), OXiGENE Inc (NASDAQ:OXGN), Opexa Therapeutics Inc (NASDAQ:OPXA), 22nd Century Group Inc (NYSEMKT:XXII)

Shares of Neuralstem (NYSEMKT:CUR) , a clinical-stage biopharmaceutical company focused on treating central nervous system disorders through neural stem-cell therapies, advanced as much as 13% after reporting final phase 1 results utilizing NSI-566 in treating amyotrophic lateral sclerosis. Neuralstem, Inc. (NYSEMKT:CUR) stock performance was 12.05% in last session and finished the day at $4.37. Traded volume was 4,029,043 million shares in the last session and … Continue reading Biotech Gainers: Neuralstem (NYSEMKT:CUR), OXiGENE Inc (NASDAQ:OXGN), Idera Pharmaceuticals (NASDAQ:IDRA), Five Prime Therapeutics (NASDAQ:FPRX)